Loading...

Pharmacological concentrations of rFVIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice

BACKGROUND: Recombinant factor VIIa (rFVIIa) has been used widely for treating hemophilia patients with inhibitory autoantibodies against factor VIII or IX. Its mechanism of action is not entirely known. A majority of in vitro studies suggested that pharmacological concentrations of rFVIIa restore h...

Full description

Saved in:
Bibliographic Details
Published in:J Thromb Haemost
Main Authors: KESHAVA, S., SUNDARAM, J., RAJULAPATI, A., PENDURTHI, U.R., RAO, L.V.M.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785069/
https://ncbi.nlm.nih.gov/pubmed/26727350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13244
Tags: Add Tag
No Tags, Be the first to tag this record!